Work

Contemporary Approaches to Melanoma Detection and Advanced Therapeutics

Year: 2026
Type: article
Abstract: Cutaneous melanoma is a highly aggressive form of skin cancer, which accounts for up to 80% of skin cancer-related deaths worldwide. Despite significant advances in melanoma treatment for the past 15 years, the established therapies with BRAFi/MEKi and immunotherapy with checkpoint inhibitors (ICIs) suffer from acquired and intrinsic resistance, as well as adverse side effects. Due to the limited specificity of currently employed diagnostic probes, an urgent need exists for a new generation of molecular probes that can selectively target malignant melanoma lesions and provide adequate information on the stage and progress of the disease. This review highlights the most recent advances made in 2025–2026 in melanoma treatment and detection. In the first section, new selective PET tracers and fluorescent probes for diagnosis and staging of melanoma are discussed. The second section discusses diverse approaches to melanoma treatment, such as novel small-molecule drugs capable of overcoming resistance to BRAFi/MEKi and increased sensitivity to ICIs, multi-action nanoformulations, biocompatible microneedle patches for efficient transdermal drug delivery, and novel immunotherapy approaches. Together, this review illustrates that further research in the treatment and diagnosis of melanoma is moving toward new molecular targets, efficient drug combinations, and patient-specific therapy.
Language: English
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7236741817
FWCI:
Cites: 226
Cited by:
Related to: 10